TetraLogic Pharmaceuticals Corp (TLOG)

OTC Markets
Currency in USD
0.0001
0.0000(0.00%)
Closed·
TLOG Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week High
Fair Value
Day's Range
0.00010.0001
52 wk Range
0.00010.0001
Key Statistics
Edit
Prev. Close
0.0001
Open
0.0001
Day's Range
0.0001-0.0001
52 wk Range
0.0001-0.0001
Volume
-
Average Volume (3m)
10.34K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TLOG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

TetraLogic Pharma Company Profile

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Compare TLOG to Peers and Sector

Metrics to compare
TLOG
Peers
Sector
Relationship
P/E Ratio
0.0x−3.8x−0.5x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x2.0x2.6x
Price / LTM Sales
0.0x25.9x3.0x
Upside (Analyst Target)
0.0%199.4%48.7%
Fair Value Upside
Unlock−0.6%9.2%Unlock

Earnings

Latest Release
Nov 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the TetraLogic Pharma (TLOG) Stock Price Today?

The TetraLogic Pharma stock price today is 0.00.

What Stock Exchange Does TetraLogic Pharma Trade On?

TetraLogic Pharma is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for TetraLogic Pharma?

The stock symbol for TetraLogic Pharma is "TLOG."

What Is the TetraLogic Pharma Market Cap?

As of today, TetraLogic Pharma market cap is 2.43K.

What Is TetraLogic Pharma's Earnings Per Share (TTM)?

The TetraLogic Pharma EPS (TTM) is -1.64.

From a Technical Analysis Perspective, Is TLOG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has TetraLogic Pharma Stock Split?

TetraLogic Pharma has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.